Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID... see more

TSXV:CLAS.H - Post Discussion

Claritas Pharmaceuticals Inc > I forgot, we got a good relationship with Salzman
View:
Post by Dude51 on Feb 21, 2021 12:52pm

I forgot, we got a good relationship with Salzman

and that is a big bonus at this time. GLTA
Comment by Scotty on Feb 22, 2021 12:12am
Lol the company we're giving millions to has good relations with us. Thanks for the big brained take Dude.
Comment by Dude51 on Feb 22, 2021 8:40am
So I prepared the last email and somehow spell checker in word 2010 changed Don't forget to "I" forget. Sorry for the misses understanding Scotty. I no how big you are on speeling. lol
Comment by Scotty on Feb 22, 2021 9:47am
Embarrassing.
Comment by Dude51 on Feb 22, 2021 10:10am
That's all you got, slow day in BS land?
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities